PHAXIAM Therapeutics S.A. Proceeds From Issuing Other Equity Instruments
PHAXIAM Therapeutics S.A. reported Proceeds From Issuing Other Equity Instruments of EUR 0 for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-28.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssuingOtherEquityInstruments · last filed 2023-03-28
| Period end | Proceeds From Issuing Other Equity Instruments 6 month | Proceeds From Issuing Other Equity Instruments 12 month |
|---|---|---|
| 2022-12-31 | 0.00 EUR 20-F · filed 2023-03-28 | |
| 2021-12-31 | 0.00 EUR 20-F · filed 2023-03-28 | |
| 2021-06-30 | 0.00 EUR 6-K · filed 2021-09-20 | |
| 2020-12-31 | 12.00K EUR 20-F · filed 2023-03-28 | |
| 2020-06-30 | 12.00K EUR 6-K · filed 2021-09-20 | |
| 2019-12-31 | 47.00K EUR 20-F · filed 2022-04-27 | |
| 2018-12-31 | 0.00 EUR 20-F · filed 2021-03-08 |